Current stock page

Catalysts

PRCT Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - DevicesScore data as of Nov 18, 2026

PRCTPROCEPT BioRobotics Corporation

Healthcare / Medical - Devices

Low Priority

In Line With Peers

BearishEdge 5/10
$25.18+$1.40 (+5.89%)

Latest quote

  • Momentum
    60
  • Value
    38
  • Quality
    45
  • Risk resilience
    45
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Feb 24, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 49/100

Momentum 60/100 and sentiment — before the next covered event.

Recent coverage
4 articles

Updated Nov 18, 2026 · Sentiment 10.12%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 60/100AIQ Edge 5/10 In Line With Peers
Beat rate
38%
3 of 8 reported periods
Average surprise
-7.4%
Across covered historical reports
Latest result
-17.5%
Nov 4, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 4, 2026—-$0.39-$0.46-17.5%$100.52M$98.29M
Aug 4, 2026—-$0.46-$0.47-1.8%$92.77M$94.5M
Apr 29, 2026—-$0.55-$0.56-1.8%$80.52M$83.13M
Feb 25, 2026—-$0.32-$0.53-65.6%$93.77M$76.38M
Nov 4, 2025—-$0.41-$0.38+7.3%$93.7M$83.33M
Aug 6, 2025—-$0.41-$0.35+14.6%$84.35M$79.18M
Apr 24, 2025—-$0.49-$0.45+8.2%$65.44M$69.16M
Feb 25, 2025—-$0.34-$0.35-2.9%$75.98M$68.24M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Hold
5
Buy
9
Hold
1
Sell
12-month analyst target
$30.00
+19.14% versus current price
Based on 15 analyst observations. Targets are estimates, not predictions.
Low target
$30.00
+19.14% vs latest price
Average target
$30.00
+19.14% vs latest price
High target
$30.00
+19.14% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateFeb 24, 2027

Next known earnings or reporting date.

EPS estimate-$0.25

Current analyst expectation for the upcoming report.

Revenue estimate$119.86M

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score60

Where event reaction would show up first.

AIQ score49/100

Composite decision read before event confirmation.

Analyst context

Consensus
Hold
Analysts
15
Average target
$30.00
Target upside
19.14%
Target range
$30.00 - $30.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
2
Neutral
1
Negative
1
seekingalpha.com · Nov 5, 2026

PROCEPT BioRobotics Corporation (PRCT) Q3 2026 Earnings Call Transcript

PROCEPT BioRobotics Corporation (PRCT) Q3 2026 Earnings Call November 4, 2026 4:30 PM ESTCompany ParticipantsLarry Wood - President, CEO & DirectorKevin...

zacks.com · Nov 4, 2026

PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Lags Revenue Estimates

PROCEPT BIOROBO (PRCT) delivered earnings and revenue surprises of -17.95% and -1.78%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

gurufocus.com · Oct 20, 2026

PROCEPT BioRobotics Corp (PRCT) Shares Surge 4.0% -- What GF Score of 71 Tells Investors

On October 19, 2026, PROCEPT BioRobotics Corp (PRCT) shares rose 4.0% to a current price of $18.28. This price is within a 52-week range of $16.67 to $38.11, re

markets.businessinsider.com · Sep 4, 2026

PRCT INVESTOR DEADLINE: PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action Lawsuit Before September 22, 2026

San Francisco, California--(Newsfile Corp. - September 4, 2026) - Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporat...

Open full news and sentiment

PRCT Catalysts FAQ

What are the next catalysts for PRCT stock?

PRCT's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move PRCT stock?

Upcoming events that could move PRCT include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could PRCT's next earnings report affect the stock?

PRCT's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive PRCT stock higher?

PRCT could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt PRCT stock?

PRCT could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.